Chronic clenbuterol administration negatively alters cardiac function

Medicine and Science in Sports and Exercise

Volumn 34, Issue 4, 2002, Pages 643-650

  Sleeper, Margaret M ^a   Kearns, Charles F ^a   McKeever, Kenneth H ^a  

^a Equine Exercise Physiol Laboratory   (United States)

Author keywords

Clenbuterol; Echocardiography; Equine; Exercise testing

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; AORTA RUPTURE; ARTERY DIAMETER; ARTICLE; BETA ADRENERGIC STIMULATION; CARDIOTOXICITY; CONTROLLED STUDY; DIASTOLE; DRUG MECHANISM; EXERCISE; EXERCISE TEST; FEMALE; HEART FUNCTION; HEART FUNCTION TEST; HEART LEFT VENTRICLE; HEART PERFORMANCE; HEART SIZE; HEART VENTRICLE SEPTUM; HORSE; LONG TERM EXPOSURE; M MODE ECHOCARDIOGRAPHY; NONHUMAN; RISK ASSESSMENT; SYSTOLE; THICKNESS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND TRANSDUCER;

EID: 0036118015     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-200204000-00013     Document Type: Article

References (36)

1. Biochemical markers of myocardial injury. Is MB creatine kinase the choice of the 1990's?
2. Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers
3. Beta-adrenergic regulation of a myocardial actin gene via a cyclic AMP-independent pathway
4. Sudden and unexpected death in adult horses
5. Skeletal muscle protein synthesis and growth hormone secretion in young lambs treated with clenbuterol
6. Concentration of cardiac troponin I in a horse with a ruptured aortic regurgitation jet lesion and ventricular tachycardia
7. Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse
8. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats
9. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD)
10. 2+-indepenent kinase activity increases during either hypertrophy or running
11. Clenbuterol-supported dynamic training of skeletal muscle ventricles against systemic load: A key for powerful circulatory assist?
12. Interaction between clenbuterol and run training: Effects on exercise performance and MLC isoform content
13. Clenbuterol administration disrupts central mechanisms of aerobic performances in the horse
14. The acute unwanted effects of β2 receptor agonist therapy
15. The effect of clenbuterol chloride on the mucociliary transport rate in horses with a clinical diagnosis of chronic obstructive pulmonary disease (COPD)
16. Effects of training intensity on maximum oxygen uptake
17. A review of toxicology of salbutamol (albuterol)
18. Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles
19. Cardiac intracellular calcium release channels: Role in heart failure
20. Causes of poor performance of horses during training, racing, or showing: 348 Cases (1992-1996)
21. Calcium/calmodulin-dependent protein kinases
22. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay
23. The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep
24. Echocardiography in the horse
25. Clenbuterol: A substitute for anabolic steroids?
26. Echocardiographic examination in the horse: The basics
27. Appropriate roles of cardiac troponins in evaluating patients with chest pain
28. Use of a β-agonist to alter fat and muscle deposition in steers
29. Effects of clenbuterol hydrochloride on certain respiratory and cardiovascular parameters in horses performing treadmill exercise
30. Nab 365, a beta 2 receptor sympathomimetic agent: Clinical experience in horses with lung disease
31. Cardiopulmonary effects of clenbuterol in the horse
32. Elevated serum cardiac markers in asymptomatic marathon runners after competition: Is the myocardium stunned?
33. Respiratory mechanics of horses during stepwise treadmill exercise tests, and the effect of clenbuterol pretreatment on them
34. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats
35. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features